<SEC-DOCUMENT>0001628908-23-000149.txt : 20231016
<SEC-HEADER>0001628908-23-000149.hdr.sgml : 20231016
<ACCEPTANCE-DATETIME>20231013173553
ACCESSION NUMBER:		0001628908-23-000149
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230119
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231016
DATE AS OF CHANGE:		20231013

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evolent Health, Inc.
		CENTRAL INDEX KEY:			0001628908
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		IRS NUMBER:				320454912
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37415
		FILM NUMBER:		231325797

	BUSINESS ADDRESS:	
		STREET 1:		800 NORTH GLEBE RD, SUITE 500
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22203
		BUSINESS PHONE:		571-389-6000

	MAIL ADDRESS:	
		STREET 1:		800 NORTH GLEBE RD, SUITE 500
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>evh-20230119.htm
<DESCRIPTION>10.13.23 8-K/A
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:8ad1173f-23b8-4dc5-b5cb-72d36ef5557e,g:22f4bdac-978f-4f69-a6c6-b381de4f6061,d:769b8d5de37f41d39605001af30e010a--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>evh-20230119</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-22">January 19, 2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001628908</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">true</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="evh-20230119.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001628908</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-19</xbrli:startDate><xbrli:endDate>2023-01-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i769b8d5de37f41d39605001af30e010a_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K/A</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 19, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)  &#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Evolent Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.472%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37415</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">32-0454912</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commission File Number:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">800 N. Glebe Road</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 500</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Arlington</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Virginia</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">22203</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)(zip code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">571</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">389-6000</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report.)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric>  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric>  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric>  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric>  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:31.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">EVH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i769b8d5de37f41d39605001af30e010a_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">EXPLANATORY NOTE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As previously indicated, Evolent Health, Inc. (&#8220;Evolent&#8221;) is filing this Amendment No. 2 on Form 8-K/A to Evolent&#8217;s Current Report on Form 8-K filed with the SEC on January 23, 2023 (the &#8220;Original Form 8-K&#8221;) and amended on September 26, 2023 (&#8220;Amendment No. 1&#8221;), to provide the restated financial results of NIA (as defined in Amendment No. 1) as of September 30, 2022 and December 31, 2021 and for the nine months ended September 2022 and 2021 to replace the financial statements filed as Exhibit 99.2 to the Original Form 8-K, and revised pro forma financial information of Evolent as of and for the nine months ended September 30, 2022, to replace the pro forma financial information of Evolent as of and for the nine months ended September 30, 2022, included as part of Exhibit 99.3 to the Original Form 8-K.  Except for the foregoing, this Amendment does not modify, update or replace any disclosure contained or filed in an exhibit to the Original Form 8-K or Amendment No. 1. </span></div><div><span><br/></span></div><div id="i769b8d5de37f41d39605001af30e010a_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Item 9.01.  Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Financial Statements of Business Acquired.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The restated unaudited financial statements of Magellan Specialty Health, a business of Magellan Parent (&#8220;Magellan&#8221;), comprised of the condensed combined balance sheets as of September 30, 2022 and December 31, 2021, the related condensed combined statements of operations, cash flows and equity for each of the nine months ended September 30, 2022 and 2021 and the related notes to the condensed combined financial statements, are attached hereto as  Exhibit 99.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma Financial Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Restated unaudited pro forma condensed combined financial information of the Company as of and for the nine months ended September 30, 2022, giving effect to the Closing, is attached hereto as Exhibit 99.2.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.269%"><tr><td style="width:1.0%"></td><td style="width:14.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit991.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit991.htm">Restated unaudited financial statements of Magellan Specialty Health as of September 30, 2022 and December 31, 2021 and for each of the nine months ended September 30, 2022 and 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992.htm">99.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992.htm">Restated unaudited pro forma condensed combined financial information of the Company as of and for the nine months ended September 30, 2022</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i769b8d5de37f41d39605001af30e010a_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES </span></div><div style="text-indent:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: October 13, 2023</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.269%"><tr><td style="width:1.0%"></td><td style="width:19.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EVOLENT HEALTH, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Jonathan Weinberg</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Weinberg</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel and Secretary</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i314ba681891f40fd811d53ce960b72a7_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="margin-top:0.15pt;text-align:right"><img alt="magellanlogoa.jpg" src="magellanlogoa.jpg" style="height:182px;margin-bottom:5pt;vertical-align:text-bottom;width:441px"></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:400;line-height:100%">COMBINED UNAUDITED FINANCIAL STATEMENTS</font></div><div style="margin-top:0.15pt;text-align:center"><font><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:400;line-height:100%">MAGELLAN SPECIALTY HEALTH</font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A Business of Magellan Health, Inc.)</font></div><div style="margin-top:0.15pt;text-align:center"><font><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:400;line-height:100%">September 30, 2022</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i314ba681891f40fd811d53ce960b72a7_4"></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MAGELLAN SPECIALTY HEALTH</font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A Business of Magellan Health, Inc.)</font></div><div style="margin-top:0.15pt;text-align:center"><font><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">COMBINED FINANCIAL STATEMENTS</font></div><div style="margin-top:0.15pt;text-align:center"><font><br></font></div><div style="margin-bottom:16pt;margin-top:56pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Contents</font></div><div style="padding-left:9.35pt;padding-right:54pt;text-indent:-9.35pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.974%"><tr><td style="width:1.0%"></td><td style="width:96.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Combined Balance Sheets as of December 31, 2021 and September 30, 2022 (unaudited)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Combined Statements of Income (unaudited)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Statements of Net Parent Investment (unaudited)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Combined Statements of Cash Flows (unaudited)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes to Combined Financial Statements (unaudited)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.974%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:25.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i314ba681891f40fd811d53ce960b72a7_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.177%"><tr><td style="width:1.0%"></td><td style="width:66.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">MAGELLAN SPECIALTY HEALTH</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(A Business of Magellan Health, Inc.)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">COMBINED BALANCE SHEETS</font></div></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">As Restated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">December 31, 2021</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">As Restated September 30, 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(Unaudited)</font></div></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,975&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,161&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates, net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,418&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,965&#160;</font></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,065&#160;</font></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,743&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,770&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</font></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,650&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,687&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</font></td><td colspan="3" style="background-color:#ccedff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,279&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="4" style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,030&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,236&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,309&#160;</font></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,028&#160;</font></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,793&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,124&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Parent investment</font></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,563&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,650&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,687&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:8.45pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:148px"></div><div style="margin-top:2.55pt;padding-left:40.55pt;padding-right:22.25pt;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:119%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Refer to Note 5 &#34;Related Party Transactions&#34; for further detail. </font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:140.05pt"><font><br></font></div><div style="margin-top:4.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying notes to Combined Financial Statements.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-top:4.6pt;padding-left:140.05pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:140.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:140.05pt"><font><br></font></div><div style="margin-top:0.45pt;padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="margin-top:0.45pt;padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br><br><br><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:2.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.849%"><tr><td style="width:1.0%"></td><td style="width:65.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">MAGELLAN SPECIALTY HEALTH</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(A Business of Magellan Health, Inc.)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">COMBINED STATEMENTS OF INCOME </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">FOR THE NINE MONTHS ENDED SEPTEMBER 30,</font></div></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</font></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">As Restated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2021</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">As Restated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2022</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care and other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct service costs and other operating expenses </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,753</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,577</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense for note payable to parent </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,818</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,977</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,867</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,386</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,225</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,642&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,484&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:8.45pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:148px"></div><div style="padding-left:8.45pt"><font><br></font></div><div style="margin-top:2.55pt;padding-left:40.55pt;padding-right:22.25pt;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:119%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Refer to Note 5 &#34;Related Party Transactions&#34; for further detail. </font></div><div style="margin-top:2.55pt;padding-left:40.55pt;padding-right:22.25pt;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes stock compensation expense of $972 and $586 for the nine months ended September 30, 2021 and 2022, respectively. </font></div><div style="padding-left:8.45pt"><font><br></font></div><div style="margin-top:2.55pt;padding-left:40.55pt;padding-right:22.25pt"><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying notes to Combined Financial Statements.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:84.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MAGELLAN SPECIALTY HEALTH</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(A Business of Magellan Health, Inc.)</font></div><div style="margin-bottom:0.35pt;margin-top:6.7pt;padding-left:64.22pt;padding-right:64.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:242%">COMBINED STATEMENTS OF NET PARENT INVESTMENT</font></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</font></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">As Restated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Balance at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">     </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,177&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,642</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers to Parent</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,603&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:16pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,484</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers to Parent</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,563&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font><br></font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font><br></font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying notes to Combined Financial Statements.</font></div><div style="margin-top:0.05pt;padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.25pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:66.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.97pt;padding-right:1.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MAGELLAN SPECIALTY HEALTH</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(A Business of Magellan Health, Inc.)</font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font><br></font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMBINED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30,</font></div></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</font></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></div><div style="margin-top:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></div><div style="margin-top:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,642&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,484&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock compensation expense</font></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash income tax provision</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of effects from acquisitions of businesses&#58;</font></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,600)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates, net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,694&#160;</font></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,706)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,786)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,054&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,257&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,866)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,893)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,866)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,893)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers (to) from Parent</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at beginning of period</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at end of period</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr></table></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:8.45pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:148px"></div><div style="margin-top:2.55pt;padding-left:40.55pt;padding-right:22.25pt;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:119%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;Refer to Note 5 &#34;Related Party Transactions&#34; for further detail. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:4.7pt;padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying notes to Combined Financial Statements.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MAGELLAN SPECIALTY HEALTH</font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(A business of Magellan Health, Inc.)     </font></div><div style="margin-top:6.7pt;padding-left:58.37pt;padding-right:58.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:242%">NOTES TO COMBINED FINANCIAL STATEMENTS</font></div><div style="padding-left:1.72pt;padding-right:1.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.&#160;&#160;&#160;&#160;Organization and Nature of Operations</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying combined carve-out financial statements include the historical accounts of Magellan Specialty Health (referred to as Specialty Health or the &#8220;Company&#8221;), part of the Healthcare segment of Magellan Health, Inc. (&#34;Magellan&#34; or the &#34;Parent&#34;). Magellan was acquired by, and became a wholly owned subsidiary of, Centene Corporation (&#8220;Centene&#8221;) effective as of January 4, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is focused on delivering innovative specialty solutions for the fastest growing, most complex areas of healthcare. The Company develops innovative solutions that combine advanced analytics, agile technology and clinical excellence to drive better decision making and positively impact members' health outcomes.  The Company provides its management services primarily through&#58; (i) risk-based contractual arrangements or (ii) administrative services only (&#8220;ASO&#8221;) contractual arrangements. Additional information regarding the Company&#8217;s contractual arrangements is provided in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers include health plans for whom Magellan provides carve-out management services for areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. These management services can be applied broadly across commercial, Medicaid and Medicare populations, or on a more targeted basis for our health plan customers.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements for the fiscal years ended December&#160;31, 2020 and 2021.&#160;Footnote disclosures that would substantially duplicate the disclosures contained in the December&#160;31, 2020 and 2021 audited financial statements have been omitted from these interim financial statements, where appropriate.&#160;In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</font></div><div style="padding-right:10.85pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restatement of Previously Issued Combined Financial Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subsequent to the issuance of the combined financial statements as of and for the interim period ended September 30, 2022, we identified an error in the application of ASC Topic 606, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, related to principal accounting (gross accounting) versus agent accounting (net accounting) for risk-based contractual arrangements as well as the classification of certain assets and liabilities that were subject to offset.  It was determined that we should have applied net accounting to the risk-based contractual arrangements, so the variable consideration is based on the premiums related to the contracts less the costs to provide such services, where our previously issued combined financial statements accounted for the transactions on a gross accounting basis.  Additionally, due to the right of offset terms in certain contracts, certain assets and liabilities should have been netted against each other.  These errors overstated managed care and other revenues and cost of care, along with the associated subtotals, in our previously issued combined statements of income.  These errors also overstated accounts receivable, net, medical claims payable, and other medical liabilities, along with the associated subtotals, in our previously issued combined balance sheets.  The correction of these errors also indirectly impacted other accounts, including accrued liabilities, deferred income taxes, and net Parent investment, in our previously issued combined balance sheets, combined statement of net Parent investment, and combined statements of cash flows or disclosures, as presented in the table below.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated the effect of the error corrections detailed in the tables below on the previously issued combined financial statements, both individually and in the aggregate, in accordance with the guidance in ASC Topic 250, Accounting Changes and Error Corrections, and concluded that the effect of such errors was material to the previously issued combined financial statements as of and for the nine months ended September 30, 2022.  These corrections do not relate to or have any impact on the Company's income before income taxes and net income, which are unchanged from the previously issued combined financial statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also made other corrections to the previously issued combined financial statements related to reclassifications between depreciation and amortization expense and direct service costs and other operating expenses in the amount of $1.1 million and $1.5 million for the nine months ended September 30, 2021 and 2022, respectively.  The tables below reflect the line items of the Company&#8217;s combined financial statements that were impacted by the errors as well as these other corrections.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:22.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.906%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined Balance Sheets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</font></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,653</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,678)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,975</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,794</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,633)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,161</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates, net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,624</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,418</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,643</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,678)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,965</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,904</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,839)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,065</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,328</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,678)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,650</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,526</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,839)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,687</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,718</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,030</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,006</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,236</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims payable</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,752</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,752)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,955</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,955)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other medical liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,238</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,238)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,114)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,987</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,678)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,309</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,867</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,839)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,028</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,276</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,483)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,793</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,635</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,511)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,124</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Parent investment</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,052</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,195)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,891</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,563</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,328</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,678)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,650</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,526</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,839)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,687</font></td></tr></table></div><div style="padding-right:10.85pt"><font><br></font></div><div style="padding-right:10.85pt;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:21.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.905%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined Statement of Income</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</font></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended<br>September 30, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care and other</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,831</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339,146)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,614</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,251)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,831</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339,146)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685</font></td><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,614</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,251)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of care</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,146</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339,146)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,251</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,251)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct service costs and other operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,669</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,753</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,075</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,577</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,902</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,084)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,902</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,502)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,964</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339,146)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,818</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,228</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,251)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,977</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:15.05pt;text-indent:36pt"><font><br></font></div><div style="padding-right:10.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:51.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined Statements of Net Parent Investment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</font></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended<br>September 30, 2021 and 2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,701</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,177</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers to Parent</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,693)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(495)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,622</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,019)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,603</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,052</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,195)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers to Parent</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,231)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,891</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,563</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.840%"><tr><td style="width:1.0%"></td><td style="width:25.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined Statements of Cash Flows</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</font></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Originally Reported</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Restated</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,902</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,084)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,902</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,502)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash income tax provision</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of effects from acquisitions of businesses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,196)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,596</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,600)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,918</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,711)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates, net</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,983</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,694</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,508)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,802</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,706)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,082)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,786)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims payable and other medical liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,398</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,398)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,082)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,082</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,559</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,054</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,124</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,257</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers (to) from Parent</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,693)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(495)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,231)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,693)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(495)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,188)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,231)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,364)</font></td></tr></table></div><div style="padding-right:15.05pt;text-align:justify;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-right:15.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying applicable notes to the combined financial statements have been updated to reflect the restatement, as well as other corrections, as of December 31, 2021 and September 30, 2022 and for the interim period ended September 30, 2021 and 2022.</font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="padding-right:15.05pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Combined Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (&#34;U.S. GAAP&#34;) from the consolidated financial statements and accounting records of Magellan using the historical results of operations and historical cost basis of the assets and liabilities of Magellan that comprise Specialty Health. As of January 4, 2022, due to the acquisition of Magellan by Centene both Magellan and Specialty Health are wholly owned subsidiaries of Centene.  The operations comprising Specialty Health are in various legal entities, owned 100% by the Parent, in which Specialty Health has no direct ownership relationship.  References in these Combined Financial Statements to subsidiaries of Magellan Specialty Health refers to legal entities that are primarily engaged in operating activities that are dedicated to the business of Specialty Health. The Company&#8217;s business is primarily composed of all of the business of National Imaging Associates, Inc. (&#8220;NIA&#8221;), as well as the specialty risk business written by Magellan Providers of Texas, Inc. (&#8220;MPT&#8221;) and Magellan Life Insurance Company (&#8220;MLIC&#8221;).  Effective January 1, 2022, the risk business written by MPT and MLIC converted to non-risk.  This non-risk business is written by NIA as of January 1, 2022.  The financial statements have been derived from Magellan's historical accounting records and are presented on a carve-out basis. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically operated as part of Magellan and not as a stand-alone company and has no separate legal status or existence, this structure has continued subsequent to the acquisition by Centene. Consequently, stand-alone financial statements have not historically been prepared by Specialty Health.  The accompanying Combined Financial Statements have been prepared from Magellan&#8217;s historical consolidated financial statements and accounting records and are presented on a stand-alone basis as if the Company&#8217;s operations had been conducted independently from Magellan.  All intercompany accounts within Specialty Health have been eliminated within these statements.  As a result of Magellan&#8217;s acquisition by Centene on January 4, 2022, all of the Company&#8217;s service contracts with Centene represent related party business starting in 2022.  Refer to Note 5 &#8220;Related Party Transactions&#8221; for further detail.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combined Statements of Income include revenues and costs directly attributable to Specialty Health as well as an allocation of expenses related to functions and services provided by our Parent.  The functions and services provided by Magellan has not changed with the acquisition of Magellan by Centene.   No additional costs from Centene&#8217;s corporate functions have been allocated.  The allocation methodologies have been described within the notes to the combined financial statements where appropriate. These methodologies were primarily based on cost centers specific to the Company's operations, as well as direct labor costs incurred by Specialty Health compared to Magellan, and the Company's proportionate share of Magellan's full-time employees. These allocated costs are primarily related to corporate administrative expenses, and other corporate support services.  The allocated costs are deemed to be settled by Specialty Health to the Parent in the period in which the expense was recorded in the Combined Statements of Income.  The Combined Statements of Cash Flows present these allocated Parent functional costs as cash flows from operating activities.  Due to the inherent limitation of allocations, there can be no assurance that allocated costs represent arm&#8217;s length transactions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current and deferred income taxes and related tax expense have been determined based on the stand-alone results of the Company by applying Accounting Standards Codification No. 740,&#160;Income Taxes&#160;(&#8220;ASC 740&#8221;), to Specialty Health&#8217;s operations as if it was a separate taxpayer (i.e. following the Separate Return Methodology).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combined Balance Sheets include all assets and liabilities that are attributable to the Specialty Health business. &#160;Assets and liabilities in shared entities were included in the stand-alone financial statements to the extent the asset is primarily used by Specialty Health. If Specialty Health is not the primary user of the asset, it was excluded entirely from the Combined Financial Statements.  Any such items which exist in other entities, whether shared or otherwise, are outside of the control of Specialty Health and have been excluded from the Combined Financial Statements. Our Parent&#8217;s third-party debt and the related interest have not been allocated to us for any of the periods presented because our Parent&#8217;s borrowings are primarily for corporate cash purposes and are not directly attributable to the Company. In addition, the Company did not guarantee the debt nor is the Company jointly and severally liable for Parent's debt.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the Parent&#8217;s centralized processes and systems for cash management, payroll, purchasing, and distribution.  Accordingly, cash, related party debt and related party interest have been attributed to Specialty Health in the Combined Financial Statements only to the extent such items have been legal entitled to the Company.  The net results of these cash transactions between the Company and the Parent are reflected within net Parent investment in the accompanying combined balance sheets. In addition, net Parent investment represents the Parent&#8217;s interest in the recorded net assets of Specialty Health and represents the cumulative net investment by the Parent in Specialty Health through the dates presented, inclusive of cumulative operating results. </font></div><div style="padding-left:8.1pt;text-align:justify;text-indent:32.35pt"><font><br></font></div><div style="margin-top:0.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information included herein may not necessarily reflect the combined financial position, results of operations, changes in net Parent investment and cash flows of Specialty Health in the future or what they would have been had the Company been a separate, stand-alone entity during the periods presented. </font></div><div style="margin-top:0.15pt;text-align:justify"><font><br></font></div><div style="padding-left:8.15pt;text-align:justify;text-indent:-8.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Combination</font></div><div style="padding-left:8.15pt;text-align:justify;text-indent:-8.15pt"><font><br></font></div><div style="margin-top:0.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combined Financial Statements are presented on a stand-alone basis and include the financial position, statements of income and cash flows of Specialty Health. All significant intercompany accounts and transactions within Specialty Health have been eliminated in the accompanying Combined Financial Statements. All intercompany balance receivables and payables between our Parent and Specialty Health are considered settled through net transfers to Parent.  As a result of Magellan&#8217;s acquisition by Centene, in 2022 Centene completed purchase accounting for Magellan.   This purchase accounting resulted in adjustments to goodwill and intangible assets for the Company.  Centene elected to not push the adjusted goodwill and intangible asset balances from purchase accounting down to the Company, thus the accompanying financial statements do not reflect such activity.</font></div><div style="margin-top:0.15pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Parent Investment</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty Health's equity on the Combined Balance Sheets represents our Parent&#8217;s historical net investment in the Company and is presented as &#34;net Parent investment&#34; in lieu of stockholders' equity given Specialty Health has no direct ownership relationship in the various entities comprising its operations. The Combined Statements of net Parent investment include corporate allocations, net cash transfers and other property transfers between our Parent and the Company.  All transactions reflected in net Parent investment in the accompanying Combined Balance Sheets have been considered cash receipts and payments for purposes of the Combined Statements of Cash Flows and are reflected as financing activities in the accompanying Combined Statements of Cash Flows.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:8.15pt;text-align:justify"><font><br></font></div><div style="margin-top:0.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="margin-top:0.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company can include, among other things, valuation of intangible assets, medical claims payable, other medical liabilities, stock compensation assumptions, tax contingencies and legal liabilities. In addition, the Company also makes estimates in relation to revenue recognition under Accounting Standard Codification 606 (&#8220;ASC 606&#8221;) which are explained in more detail in &#8220;Revenue Recognition&#8221; below. Actual results could differ from those estimates.<br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenues are derived from business in North America. The following tables disaggregate our revenue for the nine months ended September 30, 2021 and 2022 by major service line, type of customer and timing of revenue recognition (in thousands)&#58;</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.841%"><tr><td style="width:1.0%"></td><td style="width:67.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Major Service Lines</font></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,034&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,228&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,651</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,135</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Customer</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-government</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred at a point in time</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred over time</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,685&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,363&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div style="padding-right:11.8pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Per Member Per Month (&#8220;PMPM&#8221;) Revenue. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides its management services primarily through&#58; (i) risk-based contractual arrangements, where the Company assumes all or a substantial portion of the responsibility for the cost of providing treatment services in exchange for a fixed PMPM capitation payment, or (ii) ASO contractual arrangements, where the Company provides services such as utilization review, but does not assume full responsibility for the cost of the treatment services, in exchange for an administrative fee and, in some instances, shared savings. The risk-based contracts have provisions that include &#8220;profit share.&#8221;  Under a contract with profit share provisions, if the cost to provide the care is below certain specified levels, the Company will &#8220;share&#8221; the cost savings with the customer at the percentages set forth in the contract.  In addition, certain contracts include provisions to provide the Company additional funding if the cost of care is above the specified levels.  Based on right to offset terms in certain contracts, the Company reflected accounts receivable net of the accrued liabilities related to the cost of the treatment services and profit share liability by customer.  If the customer was in a payable position the net liability was included within accrued liabilities.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Almost all of the Specialty Health revenue is paid on a PMPM basis and is inclusive of revenue from the Company&#8217;s risk-based contracts and ASO contracts for services provided to its customers. PMPM contracts generally have a term of one year or longer. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for risk-based contracts or ASO contracts is entirely variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for things such as performance incentives, performance guarantees and risk shares. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally estimates the transaction price using an expected value methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#8217;s net PMPM transaction price relates specifically to its efforts to transfer the service for a distinct increment of the series (e.g. day or month) and is recognized as revenue in the month in which members are entitled to service. The remaining transaction price is recognized over the contract period (or portion of the series to which it specifically relates) based upon estimated membership as a measure of progress.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance obligation on an activity-based contract is to stand ready to provide the activity or services purchased by the customer. The performance obligation represents a series for the duration of the arrangement. The PMPM rate is fixed per the contract&#59; however, the level of activity is variable. A majority of the Company&#8217;s transaction price relates specifically to its efforts to transfer the service for a distinct increment of the series (e.g. day or month) and is recognized as revenue when the portion of the series for which it relates has been provided.</font></div><div style="margin-top:0.1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 606-10-50-13, the Company is required to include disclosure on its remaining performance obligations as of the end of the current reporting period. The majority of the Company&#8217;s contracts meet certain exemptions as defined in ASC 606-10-50-14 through 606-10-50-14A, including (i) performance obligation is part of a contract that has an original expected duration of one year or less&#59; (ii) the right to invoice practical expedient&#59; and (iii) variable consideration related to unsatisfied performance obligations that is allocated entirely to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation, and the terms of that variable consideration relate specifically to our efforts to transfer the distinct service, or to a specific outcome from transferring the distinct service. For the Company&#8217;s contracts that pertain to these exemptions&#58; (i) the remaining performance obligations primarily relate to the provision of managed healthcare services to the customers&#8217; membership&#59; (ii) the estimated remaining duration of these performance obligations ranges from the remainder of the current calendar year to three years&#59; and (iii) variable consideration for these contracts as determined in accordance with the methodology above associated with unspecified membership that fluctuates throughout the contract.</font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Contract Assets</font></div><div style="margin-top:0.3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable and contract assets consisted of the following (in thousands)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.841%"><tr><td style="width:1.0%"></td><td style="width:50.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.955%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">January 1, 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">September 30, 2022</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,898&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,861&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:0.05pt;padding-right:14.45pt;text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2022, accounts receivable, which are included in accounts receivable and due from affiliates on the combined balance sheets, decreased by ($8.0) million, mainly due to customer settlements received for prior years and terminated contracts.  In the nine months ended September 30, 2022, contract assets, which are included in accounts receivable and other current assets on the combined balance sheets, decreased by ($0.3) million, mainly due to timing of settlement of shared savings with customers.  </font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable consists of amounts due from customers throughout the United States. Collateral is generally not required. A majority of the Company&#8217;s contracts have payment terms in the month of service, or within a few months thereafter. The timing of payments from customers from time to time generates contract assets or contract liabilities, however these amounts are immaterial.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable is net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Management elected to disaggregate trade receivables into business segments due to risk characteristics unique to each platform given the individual lines of business and market. Pooling was further disaggregated based on either geography or product type.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leveraged historical write offs over a defined lookback period in deriving a historical loss rate. The expected credit loss model further considers current conditions and reasonable and supportable forecasts through the use of an adjustment for current and projected macroeconomic factors. Management identified appropriate macroeconomic indicators based on tangible correlation to historical losses, giving consideration to the location and risks associated with the Company&#8217;s customers.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant Customers</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers exceeding ten percent of the combined Company&#8217;s net revenues</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was one customer that generated in excess of ten percent of net revenues for the nine months ended September 30, 2021 and 2022 (in thousands)</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:2.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.341%"><tr><td style="width:1.0%"></td><td style="width:41.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Customer</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Date</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ccedff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</font></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$66,428</font></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$106,899</font></td></tr></table></div><div style="padding-left:2.75pt"><font><br></font></div><div><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:148px"></div><div style="margin-top:0.05pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This customer&#8217;s contract switched from a risk-based contractual arrangement to a ASO contractual arrangement effective January 1, 2022.  Effective January 4, 2022, this is related party revenue.  Refer to Note 5 &#8220;Related Party Transactions&#8221; for further detail.</font></div><div style="margin-top:0.05pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Income Tax </font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate from continuing operations was an expense of&#160;26.1 percent for both the nine-month periods ended&#160;September 30, 2021 and 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the stand-alone approach used to determine the deferred income taxes, the Company has no net operating losses to reduce federal, state, or local taxable income in 2022 and subsequent years. &#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Uncertain Tax Positions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Magellan continually performs a comprehensive review of its tax positions and accrues amounts for tax contingencies related to uncertain tax positions. Based upon these reviews, no uncertain tax positions were related to the Company and no uncertain tax positions were identified on a stand-alone basis. &#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. Commitments and Contingencies </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Issues</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The managed healthcare industry is subject to numerous laws and regulations. The subjects of such laws and regulations cover, but are not limited to, matters such as licensure, accreditation, government healthcare program participation requirements, information privacy and security, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Over the past several years, government activity has increased with respect to investigations and&#47;or allegations concerning possible violations of fraud and abuse and false claims statutes and&#47;or regulations by healthcare organizations and insurers. Entities that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as regulatory actions unknown or unasserted at this time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, regulators of certain of the Company&#8217;s subsidiaries may exercise certain discretionary rights under regulations including increasing their supervision of such entities, requiring additional restricted cash or other security or seizing or otherwise taking control of the assets and operations of such subsidiaries.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating activities entail significant risks of liability. From time to time, the Company is subject to various actions and claims arising from the acts or omissions of its employees, network providers or other parties. In the normal course of business, the Company receives reports relating to deaths and other serious incidents involving patients whose care is being managed by the Company. Such incidents occasionally give rise to malpractice, professional negligence and other related actions and claims against the Company or its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">network providers. Many of these actions and claims received by the Company seek substantial damages and therefore require the Company to incur significant fees and costs related to their defense.</font></div><div style="margin-top:0.15pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to or party to certain class actions and other litigation and claims relating to its operations or business practices, including network provider reimbursement, employment practices and privacy and data protection. The Company has recorded reserves that, in the opinion of management, are adequate to cover litigation, claims or assessments that have been or may be asserted against the Company, and for which the outcome is probable and reasonably estimable. Management believes that the resolution of such litigation and claims will not have a material adverse effect on the Company&#8217;s financial condition or results of operations&#59; however, there can be no assurance in this regard.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. Related Party Transactions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the Company has been managed and operated in the normal course of business consistent with other affiliates of the Parent. Accordingly, certain shared costs have been allocated to Specialty Health and reflected as expenses in the Combined Financial Statements. Management considers the allocation methodologies used to be reasonable and appropriate reflections of the historical Parent expenses attributable to Specialty Health for purposes of the stand-alone financial statements. However, the expenses reflected in the Combined Financial Statements may not be indicative of the actual expenses that would have been incurred during the periods presented if Specialty Health historically operated as a separate, stand-alone entity. In addition, the expenses reflected in the Combined Financial Statements may not be indicative of related expenses that will be incurred in the future by Specialty Health.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of Magellan&#8217;s acquisition by Centene as of January 4, 2022, all of the Company&#8217;s service contracts with affiliate entities of Centene represent related party business starting in 2022.  On the accompanying September 30, 2022 combined balance sheet, all related party balances have been reflected as a net due from affiliates of $19.4 million.  At December 31, 2021, since Centene was not a related party the Centene balance of $24.6 million was disclosed within accounts receivable, net.  The related party net revenue from the Company&#8217;s service contracts with Centene for the nine months ended September 30, 2022 were $106.9 million.   The comparable balances for the nine months ended September 30, 2021 were $66.4 million. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Centralized Treasury</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury activities, including activities related to the Company, are centralized by the Parent such that net cash collections and disbursements are generally distributed to the Parent and reflected as net Parent investment.  Settlement of Specialty Health's transactions with the Parent are considered to be financing transactions, which are presented as Net Transfers to Parent in the accompanying combined statements of cash flows.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Corporate Overhead &#47; Costs</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combined statements of income include costs related to employees within shared services centers that were fully dedicated to the Company based on identification of cost centers specific to the Company&#8217;s operations.  These costs are primarily related to administrative and other corporate support services.   The combined balance sheets include the accruals of $14.2 million and $13.6 million at December 31, 2021 and September 30, 2022, respectively, related to the costs of such employees, which are included in accounts payable, accrued liabilities and other long-term liabilities.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain of Magellan&#8217;s corporate overhead costs were allocated to the Company using Magellan&#8217;s allocation methodologies described in Note 2 &#8220;Summary of Significant Accounting Policies.&#8221;  A portion of these allocated costs include expenses related to employees that were not considered to be fully dedicated to the Company.  As these corporate overhead expenses are considered intercompany transactions, the allocated costs are deemed to be settled when incurred and are included in the net Parent investment on the combined balance sheets.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total costs associated with these charges, including the costs of both the fully dedicated employees through shared services centers and the allocated costs from Magellan to the Company described above, were of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$126.1 million and $133.7 million for the nine months ended September 30, 2021 and 2022, respectively, which are included in the direct service costs and other operating expenses on the combined statements of income.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Payable </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2013, the Company executed a $150.0 million intercompany note agreement with a subsidiary of the Parent (the &#8220;Note&#8221;).  The Note bore interest at a rate of the Prime Rate plus 1.5 percent.  At December 31, 2019 the Note balance was $40.0 million.  In the year ended December 31, 2020, the Company repaid $5.0 million of the Note.  In December 2021, the Note was assigned by the Parent to the Company, effectively resulting in the cancellation of the Note agreement through a non-cash transaction.    </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. Subsequent Events</font></div><div style="margin-top:0.1pt;text-align:justify"><font><br></font></div><div style="margin-top:4.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, Magellan Health, Inc. and Magellan Healthcare, Inc. executed a definitive agreement to sell Magellan&#8217;s Specialty Health business to Evolent Health, Inc. (&#8220;Evolent&#8221;) (collectively the &#8220;Sale&#8221;).   Given MPT and MLIC no longer have any specialty business, the only legal entities included in the Sale are NIA and its non-dissolved subsidiaries. The Sale closed on January 20, 2023, resulting in NIA becoming a wholly owned subsidiary of Evolent.  In addition to the Sale, Evolent and Centene are expanding Centene&#8217;s relationship with NIA, now a part of Evolent, and extending NIA&#8217;s contracts with Centene through 2027. </font></div><div style="margin-top:4.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events of which it is aware occurring after September 30, 2022 through October 11, 2023, the date the financial statements were available to be issued.  The Company did not have any material recognizable subsequent events during this period other than the item described above.</font></div><div style="margin-top:4.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font></div><div style="margin-top:0.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if4d113d8ae8c4491892aa50612fd528a_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Exhibit 99.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following restated unaudited pro forma combined financial statements (&#8220;pro forma financial statements&#8221;) have been prepared based on the historical consolidated financial statements of Evolent Health, Inc. (&#8220;Evolent&#8221;, &#8220;we&#8221;, &#8220;the Company&#8221;) to give effect to the following transaction (the &#8220;Transaction&#8221;)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, Evolent and Evolent Health LLC (&#8220;EVH LLC&#8221; and, together with Evolent, the &#8220;Evolent Entities&#8221;), entered into a Stock and Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Magellan Health, Inc. (&#8220;Magellan Parent&#8221;) and Magellan Healthcare, Inc. (&#8220;Magellan&#8221; and together with Magellan Parent (and all applicable subsidiaries), the &#8220;Magellan Entities&#8221;), pursuant to which, subject to the satisfaction or waiver of certain conditions, EVH LLC agreed to (i) acquire all of the outstanding shares of capital stock of National Imaging Associates, Inc., a wholly-owned subsidiary of Magellan, and (ii) acquire certain assets held by Magellan Parent and&#47;or certain of its subsidiaries that are used in the Magellan Specialty Health Division (collectively, &#8220;Magellan Specialty Health&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of and as set forth in the Purchase Agreement, the Evolent Entities paid $387.8 million of cash consideration (inclusive of certain post-closing adjustments) and issued 8,474,576 shares of Evolent&#8217;s Class A common stock (&#8220;Class A Shares&#8221;), fair valued at $261.3 million as of January 20, 2023 (the &#8220;Transaction Consideration&#8221;). The Transaction Consideration is subject to certain post-Closing adjustments and deductions related to, among other things, net working capital, cash and indebtedness of Magellan Specialty Health.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Transaction Consideration, Magellan Parent shall be eligible to receive, subject to the satisfaction of certain metrics set forth in the Purchase Agreement, including those related to the achievement of certain operating results during calendar year 2023 (the &#8220;Earnout Period&#8221;), or upon the occurrence of certain events, additional consideration of up to $150.0 million payable in cash and Class A Shares valued at a price equal to the volume weighted average closing price of such Class A Shares on the New York Stock Exchange for 20 trading days ending on the trading day that is immediately prior to two (2) business days prior to the date such payment is required to be made pursuant to the Purchase Agreement (the &#8220;Earnout Consideration&#8221;). Subject to the conditions applicable thereto, up to 50% of the Earnout Consideration may be paid in Class A Shares&#59; provided, however, the Evolent Entities may, in their discretion, increase the portion of the Earnout Consideration payable in cash and correspondingly decrease the portion of the Earnout Consideration payable in Class A Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ares Capital Management LLC and Ares Capital Corporation have provided Evolent with secured debt financing in the form of (i) additional commitments under the Company&#8217;s existing asset-based revolving credit facility in an aggregate principal amount equal to $25.0 million, and (ii) additional commitments under the existing initial term loan facility in an aggregate principal amount equal to $240.0 million (clauses (i) and (ii), the &#8220;Acquisition Facilities&#8221;), and certain amendments to the Company&#8217;s existing credit agreement have been made. Additionally, Ares has purchased from Evolent an aggregate $175.0 million initial liquidation preference of a newly issued, perpetual series of Evolent&#8217;s convertible Series A Preferred Stock. The purchase price of the convertible Series A Preferred Stock was equal to 96% of its initial liquidation preference. Each holder of convertible Series A Preferred Stock will have the right, at its option, to convert its shares of convertible Series A Preferred Stock into Class A Shares at an initial conversion price per share of $40.00 of current liquidation preference per share, subject to customary anti-dilution adjustments. The proceeds of borrowings under the Acquisition Facilities and from the sale of the Series A Preferred Stock will be used to fund the Transaction Consideration. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolent&#8217;s Current Report filed on Form 8-K with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on January 23, 2023 (the &#8220;Original Form 8-K&#8221;), financial statements of the acquired business and pro forma financial information related to the acquisition as required by Items 9.01(a) and 9.01(b) of Form 8-K were filed with the Original Form 8-K.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The previously filed pro forma financial statements for the nine months ended September 30, 2022 filed in the Original Form 8-K are being amended and refiled in this Amendment No. 2 on Form 8-K&#47;A in order to provide restated pro forma financial information of the Company for the nine months ended September 30, 2022, to replace </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the pro forma financial information of the Company for the nine months ended September 30, 2022, included as part of Exhibit 99.3 to the Original Form 8-K.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma combined statements of operations for the nine months ended September 30, 2022 give effect to the Transaction as if it had been completed on January 1, 2021. The unaudited pro forma combined balance sheet as of September 30, 2022, gives effect as if the Transaction had been completed on September 30, 2022.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma financial statements are provided for illustrative purposes only and are not intended to represent what Evolent&#8217;s financial position or results of operations would have been had the Transaction been consummated on the assumed dates, nor do they purport to project the future operating results or the financial position of the combined company following the transaction. The actual financial position and results of operations of Evolent after consummation of the Transaction may differ significantly from the pro forma amounts reflected herein due to a variety of factors. Assumptions and estimates underlying the pro forma adjustments are described in the accompanying notes, which should be read in conjunction with the pro forma financial statements. In Evolent&#8217;s opinion, all adjustments that are necessary to present fairly the pro forma information have been made. The pro forma financial statements do not include any pro forma adjustments to reflect certain expected financial benefits of the Transaction, such as cost synergies or revenue synergies, or the anticipated costs to achieve those benefits.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma financial statements should be read in conjunction with the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)&#160;&#160;&#160;&#160;Evolent&#8217;s unaudited consolidated financial statements and related notes included in Evolent&#8217;s quarterly report on Form 10-Q for the quarterly period ended September 30, 2022</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)&#160;&#160;&#160;&#160;Historical unaudited combined financial statements and related notes of Magellan Specialty Health, as restated, as of and for the nine months ended September 30, 2022 included as Exhibit 99.1 to Evolent&#8217;s current report on Form 8-K&#47;A to which these unaudited pro forma combined financial statements are attached.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA COMBINED BALANCE SHEET</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AS OF SEPTEMBER 30, 2022</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:36.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Evolent Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Magellan Specialty Health<br>(As Restated)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Transaction Accounting Adjustments</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Notes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Pro Forma Combined</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">ASSETS</font></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">156,756</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35,364</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">192,120</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Restricted cash and restricted investments</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25,057</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25,057</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">187,633</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">45,579</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(19,418)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">213,794</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,328</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">486</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(348)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,466</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></div></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">393,774</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">46,065</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,598</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">455,437</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Restricted cash and restricted investments</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13,005</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13,005</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Investments in equity method investees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,222</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,222</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property and equipment, net</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,645</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,770</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,770)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,645</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Right-of-use assets &#8211; operating</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,696</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,696</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other noncurrent assets</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,064</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">345</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(332)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,077</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Contract cost assets</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,588</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,588</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Intangible assets, net</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">451,398</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">293</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">403,707</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">855,398</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">722,790</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">113,214</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">277,671</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,113,675</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></div></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,759,182</font></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">166,687</font></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">689,874</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,615,743</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIABILITIES</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">61,863</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">792</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,533</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(g)</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">68,188</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">132,238</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">172</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">132,410</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating lease liability &#8211; current</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,053</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,053</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued compensation and employee benefits</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37,646</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,738</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(12,738)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37,646</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,524</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">326</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,850</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reserve for claims and performance - based arrangements</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">135,698</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">135,698</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></div></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">382,022</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,028</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,205)</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">388,845</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Long-term debt, net of discount</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">412,444</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">255,187</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(h)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">667,631</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other long-term liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,260</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">343</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">66,600</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">71,203</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tax receivable agreement liability</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42,870</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">70,271</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(j)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">113,141</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating lease liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">57,840</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">57,840</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred tax liabilities</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,608</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">753</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18,680</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(j) (k)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">23,041</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">903,044</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,124</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">403,533</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,321,701</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:36.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Mezzanine Equity - Series A Preferred Stock</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">168,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(l)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">168,000</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Class A common stock</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,012</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">85</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(m)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,097</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in-capital</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,472,098</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">151,563</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">109,623</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(m) (n)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,733,284</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated other comprehensive loss</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,044)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,044)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Retained earnings (accumulated deficit)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(594,805)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,633</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(g) (j)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(586,172)</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Treasury stock</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(21,123)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(21,123)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">856,138</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">151,563</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">118,341</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,126,042</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 34.27pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Total liabilities, mezzanine equity and shareholders' equity</font></td><td style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,759,182</font></td><td style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">166,687</font></td><td style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">689,874</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,615,743</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA COMBINED STATEMENT OF INCOME</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands, except for per share amounts)</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Evolent Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Magellan Specialty Health<br>(As Restated)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Transaction Accounting Adjustments</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Notes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#221e20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Pro Forma Combined</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Revenue</font></td><td style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">969,581</font></td><td style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">194,363</font></td><td style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,163,944</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:8pt"><font><br></font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Expenses</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cost of revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">736,061</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">99,582</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">835,643</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Selling, general and administrative expenses</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">186,408</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,995</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">228,403</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Depreciation and amortization expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">47,414</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,400</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,535</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d) (o)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">75,349</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Change in fair value of contingent consideration</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(5,822)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(5,822)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total operating expenses</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">964,061</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">144,977</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,535</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center;text-indent:20pt"><font><br></font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,133,573</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 20.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating income (loss)</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,520</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">49,386</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,535)</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center;text-indent:20pt"><font><br></font></div></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,371</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right;text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;765 </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">765</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </font></div></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(9,143)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(40,548)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(p)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(49,691)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain form equity method investees </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,940</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,940</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax receivable agreement liability </font></div></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(42,870)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42,870</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(j)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on repayment of debt </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(10,192)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(10,192)</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </font></div></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right;text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;130 </font></div></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">130</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Income (loss) from continuing operations before income taxes</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(51,850)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">49,386</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(22,213)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,677)</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Provision (benefit) for income taxes</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(44,498)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,902</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,194</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(q)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,402)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.27pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Income (loss) from continuing operations</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,352)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36,484</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(52,407)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(23,275)</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dividends and accretion of Series A Preferred Stock</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(23,918)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(r)</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(23,918)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net income (loss) attributable to common shareholders of Evolent Health, Inc.</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,352)</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36,484</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(76,325)</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(47,193)</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Loss per common share</font></td><td colspan="3" style="background-color:#ccecff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Basic and diluted loss per share attributable to common shareholders (t)</font></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.08)</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right;text-indent:20pt"><font><br></font></div></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right;text-indent:20pt"><font><br></font></div></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center;text-indent:20pt"><font><br></font></div></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.47)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Weighted-Average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Basic and diluted (t)</font></td><td colspan="3" style="background-color:#ccecff;border-bottom:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">91,643</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right;text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#ccecff;border-bottom:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,475</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 2.37pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font></td><td colspan="3" style="background-color:#ccecff;border-bottom:3pt double #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">100,118</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOTES TO THE UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. Basis of Presentation</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X, as amended, including pursuant to SEC Final Rule, Amendments to Financial Disclosures about Acquired and Disposed Businesses, release number 33-10786 dated May 20, 2020 (&#8220;Article 11&#8221;), using the acquisition method of accounting under U.S. GAAP. Transaction accounting adjustments have been made to show the effects of the Transaction on the combined historical financial statements of Evolent and Magellan Specialty Health. A reclassification adjustment has been made to the historical presentation of Magellan Specialty to conform to the financial statement presentation of Evolent Health, Inc for the unaudited pro forma condensed combined financial information as noted below. Refer to Note 3 &#8211; Reclassification of Magellan Specialty Health&#8217;s Combined Statements of Income for further details on the reclassification adjustment.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 2. Acquisition of Magellan Specialty Health </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2023, Evolent and Evolent Health LLC (&#8220;EVH LLC&#8221; and, together with Evolent, the &#8220;Evolent Entities&#8221;), completed its acquisition of National Imaging Associated Inc. (&#8220;NIA&#8221;), including all of the issued and outstanding shares of capital stock of NIA as well as certain assets held by Magellan Health, Inc. (&#8220;Magellan Parent&#8221;) and certain of its subsidiaries that were used in the Magellan Specialty Health Division.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of and as set forth in the Purchase Agreement, the Evolent Entities paid $387.8 million as cash consideration (inclusive of certain post-closing adjustments) and issued 8,474,576 shares Evolent&#8217;s Class A common stock (&#8220;Class A Shares&#8221;), fair valued at $261.3 million as of January 20, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Transaction Consideration, Magellan Parent shall be eligible to receive, subject to the satisfaction of certain metrics set forth in the Purchase Agreement, including those related to the achievement of certain operating results during calendar year 2023 (the &#8220;Earnout Period&#8221;), or upon the occurrence of certain events, additional consideration of up to $150.0 million payable in cash and Class A Shares valued at a price equal to the volume weighted average closing price of such Class A Shares on the New York Stock Exchange for 20 trading days ending on the trading day that is immediately prior to two (2) business days prior to the date such payment is required to be made pursuant to the Purchase Agreement (the &#8220;Earnout Consideration&#8221;). Subject to the conditions applicable thereto, up to 50% of the Earnout Consideration may be paid in Class A Shares&#59; provided, however, the Evolent Entities may, in their discretion, increase the portion of the Earnout Consideration payable in cash and correspondingly decrease the portion of the Earnout Consideration payable in Class A Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ares Capital Management LLC and Ares Capital Corporation have committed, subject to certain conditions, to provide Evolent with secured debt financing in the form of Acquisition Facilities, and certain amendments to the Company&#8217;s existing credit agreement will be made. Additionally, Evolent entered into a preferred stock financing commitment letter with Ares where Ares has committed, subject to certain conditions to purchase from Evolent an aggregate $175.0 million initial liquidation preference of a newly issued, perpetual series of Evolent&#8217;s convertible Series A Preferred Stock. The purchase price of the convertible Series A Preferred Stock will be equal to 96% of its initial liquidation preference. Each holder of convertible Series A Preferred Stock will have the right, at its option, to convert its shares of Series A Preferred Stock into Class A Shares at an initial conversion price per share of $40.00 of current liquidation preference per share, subject to customary anti-dilution adjustments. The proceeds of borrowings and Series A Preferred Stock will be used to fund the Transaction Consideration.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 3. Reclassification of Magellan Specialty Health&#8217;s Combined Statements of Income</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustments were made to Magellan Specialty Health's combined balance sheet as of September 31, 2022 and combined statement of income for the nine months ended September 30, 2022, to conform the classification and presentation of the Company&#8217;s consolidated balance sheets and consolidated statement of operations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such adjustments include (i) a reclassification adjustment of $42.0 million of direct services costs and other operating expenses into selling, general and administrative expenses on the unaudited pro forma combined statement of operations&#8217;, (ii) a $19.4 million reclassification of due from affiliates into accounts receivable, net on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the unaudited pro forma combined balance sheet and (iii) a $13.1 million reclassification of accrued liabilities into accrued compensation and employee benefits and deferred revenue on the unaudited pro forma combined balance sheet.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 4. Pro Forma Adjustments</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments included in the column labeled &#8220;Transaction Accounting Adjustments&#8221; in the pro forma balance sheet is as follows&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Reflects the $168.0 million of proceeds from issue of Series A Preferred Stock, net of issuance costs and $255.2 million of incremental long term debt, net of issuance costs which are partially offset by the $387.8 million of cash paid to the Magellan Entities for the acquisition of Magellan Specialty Health.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Removal of accounts receivable from Magellan Specialty Health which was settled prior to closing of the transaction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Adjustment for amounts that did not meet the definition of assets or liabilities for Evolent to be recognized on the balance sheet. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">(d)&#160;&#160;&#160;&#160;Reflects the removal of capitalized software, which has been replaced by a developed technology intangible, and write off of property and equipment totaling $6.8 million. The combined depreciation expense removed for both capitalized software and property and equipment was $3.3 million. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Reflects the removal of historical intangible assets and addition of identifiable intangible assets based on management&#8217;s fair valuation. Estimated useful lives are based on the time periods during which the intangibles are expected to result in substantial incremental cash flows. The following is a summary of identifiable intangible assets acquired and the related expected lives for the finite-lived intangible assets (in thousands)&#58;</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.865%"><tr><td style="width:1.0%"></td><td style="width:56.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Category</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Estimated life in years</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Fair value </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)  </font></div></td></tr><tr><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Customer relationships</font></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15</font></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">345,100</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Technology</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,700</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Corporate trade name</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</font></td><td colspan="3" style="background-color:#ccecff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,200</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total identifiable intangible assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">404,000</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;To record the preliminary fair value of goodwill resulting from the excess of consideration paid over the valuation of the net assets acquired as if the acquisition occurred as of September 30, 2022. The amount of goodwill recognized in purchase price accounting as of the acquisition closing date differs from amount shown here due to changes in certain current asset and liability balances. Goodwill resulting from the acquisition is not amortized and will be assessed for impairment at least annually.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Represents nonrecurring transaction costs of $5.5 million incurred after September 30, 2022. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Reflects the net proceeds of $255.2 million from incremental term loan facility and revolving facility of $240.0 million and $25.0 million, respectively, net of debt issuance costs of $9.8 million. These incremental loans were treated as a modification to the existing loans. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Reflects the adjustment to record a $66.6 million liability related to the fair value of the earn-out amount of contingent consideration that will be paid to the Magellan Entities if the acquired business meets the specified targets. The fair value of the earn-out is based on a range of estimated probability of revenue scenarios. The fair value of the earn-out was determined using an option pricing method and specifically a Monte Carlo simulation analysis under the income approach.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Reflects the adjustment to the amount that the Company must pay to certain investors with whom it entered into the Tax Receivables Agreement (the &#8220;TRA&#8221;). The TRA provides for the payment by the Company to these investors of 85% of the amount of the tax benefits, if any, that the Company is deemed to realize because of increases in tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. The Company removed its valuation allowance of $65.3 million as a result of deferred tax liabilities established as part of the acquisition. In connection with the valuation allowance removal, the Company has recorded an additional TRA liability of $70.3 million (making a total TRA liability to $113.1 million) as of September 30, 2022. The additional liability gave rise to additional future tax-deducted goodwill, which reduced deferred tax liabilities by $19.1 million. This resulted in a net adjustment to retained earnings of $14.2 million (decrease in deferred tax liabilities of $84.4 million, offset by recognition of $70.3 million of TRA liability). For purposes of presentation in the pro forma income statement, the change in TRA of $42.9 million was removed for the nine months ending September 30, 2022 and the full $113.1 million change was recorded for the year ended December 31, 2021 pro forma file as Amendment No. 1 on Form 8K&#47;A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Represents an adjustment to deferred tax liabilities of $103.1 million for the tax effects of recognizing the preliminary purchase price allocation reflected herein (calculated at an estimated statutory rate of 26%). These adjustments are based on estimates of the fair value of Magellan Specialty Health's assets to be acquired, liabilities to be assumed, and the related purchase price allocations. These estimates are subject to further review by Evolent's management, which may result in material adjustments to deferred taxes with an offsetting adjustment to goodwill. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Reflects the impact of $175.0 million from issuance of Series A Preferred Stock, offset in part by 4% issuance costs of $7.0 million. The Series A Preferred Stock has a liquidation preference over the Company&#8217;s common shares, with an aggregate initial liquidation preference of $175.0 million. The Series A Preferred Stock are classified as temporary equity. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Reflects the issuance of new common stock of $261.3 million (8,474,576 Class A Shares at a closing issuance price of $30.83) with par value of $0.01. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;Reflects the elimination of Magellan Specialty Health&#8217;s historical equity balance of $151.6 million.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;To remove historical amortization of the intangible assets and the recording of the pro forma amortization expense related to the identifiable intangible assets resulting from a fair valuation as if the acquisition occurred on January 1, 2021, based on preliminary estimates of the fair values of such assets and their useful lives.</font></div><div style="padding-left:37.58pt;padding-right:37.58pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:69.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">For the Nine Months Ended September 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Removal of historical amortization expense</font></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(117)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma amortization expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27,935</font></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustment for amortization expense</font></div></td><td style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ccecff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27,818</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;To remove historical interest expense on debt and its related amortization of deferred financing costs and recording of the pro forma interest expense and amortization of related debt issuance costs.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:0.08pt;padding-left:37.58pt;padding-right:37.58pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:69.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">For the Nine Months Ended September 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Removal of historical interest expense</font></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,926)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,747</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.77pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustment </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,821</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt;text-indent:30pt"><font><br></font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Removal of historical amortization of deferred financing costs</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(145)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma amortization of deferred financing costs</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,872</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma adjustment</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,727</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total pro forma adjustment</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">40,548</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was calculated to be 11.5% (Adjusted Term SOFR Rate of 5.3% on September 25, 2023 plus 6.2%) and 9.5% (Adjusted Term SOFR Rate of 4.6% on September 25, 2023 plus 4.2%) for the term loan and revolver loan, respectively. Assuming an increase in interest rates on the existing and incremental long term debt of 1&#47;8%, pro forma interest would increase by $0.5 million for the nine months ended September 30, 2022.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;Reflects an estimated income tax impact of the pro forma adjustments from the acquisition at a forecasted blended statutory tax rate of 26%. The pro forma income tax adjustments included in the pro forma statements of operations reflect the income tax effects of the transaction accounting adjustments presented, in addition to adjustments related to the release of Evolent's valuation allowance of $47.1 million. As a result of Evolent's release of the valuation allowance, income tax expense was calculated as 26% of its loss, excluding permanent items. Because the tax rates used for these pro forma financial statements are an estimate, the blended rate will likely vary from the actual effective rate in periods subsequent to completion of the acquisition.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(r)&#160;&#160;&#160;&#160;Reflects an estimated dividend and accretion on the Company's $175.0 million of Series A Preferred Stock sold to Ares Capital Corporation. The dividends on Series A Preferred Stock were calculated to be 11.5% (Adjusted Term SOFR Rate of 5.3% on September 25, 2023 plus 6.2%). Accretion was calculated based on the redemption feature of 150% of the liquidation preference using the effective interest rate over a period of six years. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)&#160;&#160;&#160;&#160;The pro forma adjustments on Evolent common stock and basic and diluted earnings per share are summarized below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:30.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.429%"><tr><td style="width:1.0%"></td><td style="width:73.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">For the Nine Months Ended <br>September 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Numerator</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Basic and diluted combined pro forma net loss attributable to common shareholders of Evolent Health, Inc.</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(47,193)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Denominator</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Historical basic and diluted weighted average Evolent shares outstanding</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">91,643</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Shares of Evolent common stock issued</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,475</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma basic and diluted weighted average Evolent shares outstanding</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">100,118</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pro forma basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc.</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.47)</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>evh-20230119.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8ad1173f-23b8-4dc5-b5cb-72d36ef5557e,g:22f4bdac-978f-4f69-a6c6-b381de4f6061-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:evh="http://www.evolenthealth.com/20230119" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.evolenthealth.com/20230119">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="evh-20230119_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="evh-20230119_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.evolenthealth.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>evh-20230119_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8ad1173f-23b8-4dc5-b5cb-72d36ef5557e,g:22f4bdac-978f-4f69-a6c6-b381de4f6061-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_c3bfdc5e-7eec-431b-99c9-281fe0550dd1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3d87f930-93d0-46e5-85f8-c8df37767af7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_57137ac8-892b-4880-93be-00ab2af04be2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c46c8e58-1337-4cbc-8f25-d47d3939b963_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_eb728007-a349-4aef-9863-1c485b6a7984_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6babb3f1-ffc9-453f-943e-72f3d489d1ce_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_480e324c-dd84-48d0-830b-c2b6081e3a19_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_555d089b-2edb-4dbc-8677-8ba29a6c6238_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e793eb29-835f-43d5-94c7-fb9b40eb4c6d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e59570a9-f48e-40db-9a71-e0ad23941beb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e72eb2f2-8696-437a-8046-2feff256263e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_0c3f1b4c-9eb3-4aab-aa61-ae8e186b57b1_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e3bb740f-40f8-41f0-85fd-4e58d3a927e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9f7c93fa-c352-40c3-8143-a36a1ad78ebe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d41b4ba6-6939-4c0e-9ab3-4b9e1284ffb3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_21652828-e8be-42b6-84f5-f645c84f800a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2537200d-e947-4d6a-aeb5-0f6792395120_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ec868f21-0efb-411e-97a2-159ee10073cd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5e19aef2-e66f-4a79-ae61-c6bb7a51aee5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_04cc31de-0e6e-4554-8b95-a68617bd74b6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f2ace484-b668-4ef9-a79b-cec587272980_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_bff354bc-f36a-4ee0-adc3-fbd071acdccd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5359fda1-a07f-4951-bd9d-fc22ad1ea29f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>evh-20230119_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8ad1173f-23b8-4dc5-b5cb-72d36ef5557e,g:22f4bdac-978f-4f69-a6c6-b381de4f6061-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.evolenthealth.com/role/Cover" xlink:type="simple" xlink:href="evh-20230119.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.evolenthealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_65c8ea1d-17e0-49d1-afbe-99b7ee17b504" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_DocumentType_65c8ea1d-17e0-49d1-afbe-99b7ee17b504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2cf05497-0753-4218-a44a-c8357f913847" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_DocumentPeriodEndDate_2cf05497-0753-4218-a44a-c8357f913847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_56319345-0dc5-4e21-a2eb-4f6ba4bc7f96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityRegistrantName_56319345-0dc5-4e21-a2eb-4f6ba4bc7f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b14f2e05-b035-49a5-ab90-b1fa92fa7314" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b14f2e05-b035-49a5-ab90-b1fa92fa7314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fe392b8b-94cc-4fd4-9db9-6a6db5b9e805" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityFileNumber_fe392b8b-94cc-4fd4-9db9-6a6db5b9e805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bc63192c-d68d-4246-9acc-6406c730f365" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityTaxIdentificationNumber_bc63192c-d68d-4246-9acc-6406c730f365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_01458762-9ebd-49e2-9363-ff9caad35c6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityAddressAddressLine1_01458762-9ebd-49e2-9363-ff9caad35c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_578b86d6-c068-424d-8be3-204db32b0a7a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityAddressAddressLine2_578b86d6-c068-424d-8be3-204db32b0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_65cfdf3e-a2ae-46e2-960f-b0a3fc3d5359" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityAddressCityOrTown_65cfdf3e-a2ae-46e2-960f-b0a3fc3d5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f903a74a-694f-470f-97dc-16ff54d8b187" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityAddressStateOrProvince_f903a74a-694f-470f-97dc-16ff54d8b187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7384081e-44b6-4314-a56a-ac521dacaaa2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_CityAreaCode_7384081e-44b6-4314-a56a-ac521dacaaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_120e7d3c-44b3-43e5-98e5-76c5d956d864" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_LocalPhoneNumber_120e7d3c-44b3-43e5-98e5-76c5d956d864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9d211670-1d36-4d87-841d-61e0fe54ad5d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityAddressPostalZipCode_9d211670-1d36-4d87-841d-61e0fe54ad5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e4068b5a-4727-449a-a457-66293632dbdc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_WrittenCommunications_e4068b5a-4727-449a-a457-66293632dbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e520854b-a62e-4950-95a1-e52bbecde94f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_SolicitingMaterial_e520854b-a62e-4950-95a1-e52bbecde94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_00fcd393-3848-4242-994a-7b731dcd48f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_PreCommencementTenderOffer_00fcd393-3848-4242-994a-7b731dcd48f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_07107e6f-b0ae-4118-ad76-c6ee72979915" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_07107e6f-b0ae-4118-ad76-c6ee72979915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_34dc95e2-a9e8-4e14-8519-07a0568261ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_Security12bTitle_34dc95e2-a9e8-4e14-8519-07a0568261ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_286b70e2-a7f7-4362-bdad-4914a287dcb7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_TradingSymbol_286b70e2-a7f7-4362-bdad-4914a287dcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a5bf5f63-fb2c-42a7-9aa6-d8543c799048" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_SecurityExchangeName_a5bf5f63-fb2c-42a7-9aa6-d8543c799048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_83be75aa-a8e7-4d19-9a43-ba9a1bb2caeb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityEmergingGrowthCompany_83be75aa-a8e7-4d19-9a43-ba9a1bb2caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b53240c5-69aa-439e-8a90-ac4035cb47b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_AmendmentFlag_b53240c5-69aa-439e-8a90-ac4035cb47b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f49c8d0e-399c-4c42-a7aa-db72252bd991" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7cc3e2f3-e3b4-4b77-b40c-4a66607b89c3" xlink:to="loc_dei_EntityCentralIndexKey_f49c8d0e-399c-4c42-a7aa-db72252bd991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@   PD    +" (   "[V59-    3$E$051X7NW6
ML0T (! #,?9?&BHXB17>KB)E@5L+ &"\??T' ,! V@@ (-H( "#:"  @V@@
K(-H( "#:"  @V@@ (+716P  :", @!R*2W6(?^Z\J0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@   P8    *" (   "!CMYE    +TE$051X7NW!
M,0$   P"(/N7UFLI!B0                          )P" +PWQ9,)=G)$
..+7T     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>magellanlogoa.jpg
<TEXT>
begin 644 magellanlogoa.jpg
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M"U*:7&I+B+^I;'7@O0,5.'>R@>40**64TE"3H2TAA! R."BJGJ4$@_&I0]6
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M[6;<=+ 9L75.M1<B UD.82_+(5!**:6T)QG:$D(((4127#T7!U)'(#YU:)<
MCPXV96";D/-K-+:EJ*.###1RP;'IA39\97_3X)AAVZX:VL9%4&C+<@B44DHI
MU25#6T(((81(S*T)2,CY)6*-0S2#/#HXC#-=CT-IMZ/:O%T=&62@J;)Y\-\L
M&\[>U1BY"XYU9X2%MJ8:*U[97<)R")122BGM78:VA!!"")&X/79DE+!$PF V
M/G488DU#D%<Q 6YWFSHRR$"2U>K"'P?#@F/=N=V,$0>;<2#,0UNKTXTM.8VX
M8UD6HD8G(FJ"QALS2BFEE-*.,K0EA!!"2#O%U?-Q,/5FED@8I,I9ULEYCZ/%
MDJZ."#*0G&QTX1<G6A&U32/,'"QN-^/Z \W851.^H6UUFQ/CCU;AR]-3$17-
M<@B44DHIU2E#6T(((82TT]!R!">S'T2<Z5K-4(]&KK'BFA_)N!>UC?O5T4 &
M"KG@V-9J!VX?3 N.=>=GC;AD7Q,6E3K4W@DO4FNM>'Y[L;<4 A<;HY122JDO
M,K0EA!!"2#MV1PU,A7]!C)$E$@:3\::A2BW;PNI9<'LB:Y7^<,/L\&!JH0V7
M[1MD"XYUYXY&7+"G";.*[&H/A0>R',+FG$;<WEX.0>N-&*644DII3S*T)800
M0DA'"BJG(-YT PZD#CLEW*.1::SQ&J05O0:+O4@=!60@J+1Y\%:F%6<-Q@7'
MNE,-;6>'46@KRR&,.UJ%2Z>;$#66Y1 HI912VD<9VA)"""&D(W5-L3B1]3.6
M2!@4CE "V^-9]Z&Q-4$= 60@R&QQX:D4"TY3@TK- ',P&F:AK:G&BN>V%[$<
M J644DK[+T-;0@@AA'3$[JA%:N&++)$P"(PWW:A84KM8O?ID(#C>Z,(#@WW!
ML>[<T8@+]S9A7G%HA[:R',(F60YA*<LA4$HII=1/,K0EA!!"2%<*JJ:R1$+$
M.QRQQB'(*/DWK(X*]<J38"(7'-M<Y<!MAYJYX%AW[FC$N;L:,3'?YNVT$*2J
M8SF$:)9#H)122JF?9&A+""&$D*[4-NW#B:S[$6>Z3B/LHY&@+(N0D/-K-%N,
MZE4GP40N./91O@U?WLL%QWIUBQFOIEG4G@LM##46_'$;RR%02BFE-  RM"6$
M$$)(5ZSV,ACRGT&,@242(M%XT_4XE/YM5#9L5*\X"285-@_>S.""8[K=8L;K
MZ:$5VEJ<;FS(;L1M2U@.@5)**:4!DJ$M(8000K3(*1^-..,UD%^CUPK^:'@:
M+ZZG7&0NMWPLG*XF]6J38)'1XL*3*6U<<,P70RRTK6QS8LR12ES"<@B44DHI
M#:0,;0DAA!"B1;5Y!XYE_1AQINLUPS\:CHY C.$J).<]CA9+IGJE2; XUNC"
MS[C@F.^&4&C+<@B44DHI#9H,;0DAA!"BA=5>#D/^'UDB(6(<@3CCM3B2?A=J
MFG:K5YD$ ZL;V%#IP*U<<*QO;C'CKQD#&]K*<@CKL\PLAT II932X,G0EA!"
M""'=D5,^!G'&(6")A/ WWC14>".*JN?" Y=ZA4F@:7!X,#'?ADNYX%C?W6K&
MGU/;8'>KG1IDBIOL&'FH A=/,R%J+,LA4$HII31(,K0EA!!"2'=4F;?A6.8/
M62(A HPU7(74PI=AL9>H5Y<$FG*;!__,L.),N> 8Z]?VW6UF/)C8BBJ[1^W9
MX'&LO V_7I^/J#&)+(= *:64TN#*T)800@@AW=%FRU/JG\HZJ%I!( T'1R#6
M. 3',G^$NN9X]<J20)/:XL+CR6W>T)&!;?_<9L;#B:VH#F)HVV)WX^/4>MRX
M((/E$"BEE%(Z,#*T)8000DA/9);^EZ%M&"M+(LC2""6U2]4K2@*)RP,<-3OQ
MTV-<<,QO!CFT+6JRX^VX<IPSV8BH<2R'0"FEE-(!DJ$M(8000GJBO&XE#J??
MB3C3#9JA( UEAR/&<#4R2OX-FZ-2O:(DD!PQNW#S02XXYE>#&-H>+FO%+]>R
M' *EE%)*0T"&MH000@CI"8LM'\GY3W"V;1@JRR*<S'X(36W)ZM4D@:31X<&?
MC&V<8>MOMYGQJZ16U(G^#12R',(R4SVN7Y#.<@B44DHI#0T9VA)"""&D-[)*
MWU86LI(S-[7"01IZQIMNP*'TVU#9L$&]BB30K"IWX*M[FUC#UM]N,^.G)UJ0
MW^96>]J_%#;:\=]8M1Q"-,LA4$HII31$9&A+""&$D-XHK5V*@VG?5NJC:@6$
M--0<CECC-<@N>Q\.9YUZ%4D@<7J OV=8$+6991'\[G8SAAUH1DRM4^UM_R'+
M(3S,<@B44DHI#449VA)"""&D-QK;DI"0\RLE"-0."6DH&6N\&DFYOT.S)4V]
M@B30F)T>/"-+(["6K?_=;L9-!YL15^>_T+;9[L82(\LA4$HII32$96A+""&$
MD-YP>QS(*/D78@Q7:H:$-'2,,UV'P^G?06W37O7JD6"@A+8&AK8!T<^A;4&C
M'6_%EN'L22R'0"FEE-(0EJ$M(8000O107#,?!U-O07SJ4,VPD Z\\:G#$&>Z
M 065T^!V6]4K1X)!J\N#%TQMB-K"T-;O^C&T/53:BH?6YK$< J644DI#7X:V
MA!!""-&#+)&0F/,;ED@(8>6U,1:^@#9;H7K52# 9EV=3%LW2#!YIW]UNQLV'
MFG&PON^AK;<<0AW+(5!**:4T?&1H2P@AA! ]>$LD_!LQAJLT T,ZD(Y K'$(
MCF;^$/7-!]0K1H)-7+T3U\0W,[CUMY^9,22N&=NJ'6I/^X8LA_!F;!G.FF1@
M.01**:64AH\,;0DAA!"BE^)J62+A9I9("#'C34.%-RK7QP.7>K5(L+&[@5&Y
M5ISUF5F9':H90%+?W=&(\W8W86:A7>UI_1PL:<6#:U@.@5)**:5A*$-;0@@A
MA.A%SN(\D?5SQ)FNU0P/Z< HRR*D%_\=5GN9>J7(0%%B<>.U= N^M+O1.^-V
M1Y< DOJNZ,,+]C1A=I'^T+;6XL3\E#I<.X_E$"BEE%(:IC*T)8000HA>[,XZ
MI!:^C!CCE9KA(0VV(Q!KN!HGLAY 4UN*>I7(0-/D\F!B@0TC#K9X0T?.NNV?
M/H:VV0TVO+BSQ#NSEN40**644AJN,K0EA!!"B"\45L]0OHH?GSI,(T2DP33>
M=(/X.0+E=9^H5X>$$@F-+OS99,&5,<V(^JS1JU8H27M69VCK]@"["IKPXT]S
MO>40)FB\^:&44DHI#1<9VA)"""'$%^J;#^)D-DLD#+S#E<7'<LI&PN%J4*\.
M"35DD+BYRHG'DMIPZ=XF[ZQ;AK>^N:,1%XJ^FU?<?6A;T^;$C,1:_-_L-&]@
MJ_7&AU)**:4TG&1H2P@AA!!?<,@2"46OL$3" !MKO!J)N8^AQ9*N7AD2RK2X
M/)A=;,/WC[7@W%V-K'?KBZ*?SA4_)^3;O)W9A:QZ&UYH+X<P+EG[30^EE%)*
M:;C)T)800@@AOE)0-4W]:CY+) R$<:;K<"3C+E2;/U.O" D7BBQN?)!CP\VR
MWJT,;5GO5I^;S7@ES:+VHA>7QX,=^4WXT<H<ED.@E%)*:>3)T)800@@AOE+3
MN O'LWZ*.-/UFJ$B#9SQLBR"Z5H45$Z%VZT]\Y"$/DE-+OPEU8*K8EGO5I=;
MS'@M_8O05I9#F)90@V_.2F4Y!$HII91&I@QM"2&$$.(K-GL%#/G/(L9PA6:P
M2 /E"*4L14K^TVBUY:A7@X0K;N&6:M:[U>46,_Z9957Z399#^/..8I9#H)12
M2FEDR]"6$$(((7TAMWP<XHQR,;+A78)%&AA'B/X>@B.9WT-=<ZQZ%4@D(.O=
MSBFVX0>RWNWN1M:[U7);(UXPMB&AM!D_^(3E$"BEE%(Z"&1H2P@AA)"^4-NX
M6RV1<)U&P$C];;SI1N%0E-0N%KTOYVB22*/8XL;(7!MN/<1ZMZ>XJPE#ME?C
MQGEI+(= *:64TL$A0UM"""&$] 6;O1+&@N<08[A2,V2D_C76. 3IQ7^'S5&N
M7@$2J:0TN?!RJA57L][M%^X1?;&RE.40**644CIX9&A+""&$D+Z27?:!&MJR
M1$+@'(%8P]4XD?T0&EL3U)XGD8Y'N*W:B=^EM.'+K'?K#6W75"!JL@E1$QC<
M4DHII700R-"6$$(((7VEO'X-#J??C3C3#1IA(_6'LBR"_%E6]ZG:ZV0PT>KR
M8%ZQ'3\ZWH+S=C<-WGJW#&TII912.MAD:$L((820OF*Q%R$E_RG$&*XZ)6RD
M_G X8HQ7(ZOT'=B=M6JOD\%(B<6-,;DVW";KW<H0<[#5NV5H2RFEE-+!)D-;
M0@@AA/2'K-)WU="6)1+\K:QCFY#[&S1;4M7>)H,=6>_VE30KKAEL]6X9VE)*
M*:5TL,G0EA!"""']@242 F.<Z7H<2K\=U>9M:D\3\@7;:YSX0XH%E^V3]6X;
M(S^\96A+*:64TL$F0UM"""&$] =OB82G62+!C\:G#E="V]SR:#A<9K6G">E,
MF]N#^26RWFTKSMO=Z"V9$*GU;F5HNZX*4=/2&-I22BFE=' X4*&MP^V 74@(
M(820\">K]&W$&*[4#""I[\88KX2AX%FTV0K4'B:D>\JL;D3GV7#[8;7>K5RL
MK&OH&>[*1=@VUB!J9H;R!D;SC0VEE%)*:209[-"VL*4,:PIW8&;&"LP0KBKX
M#"4M%>I?"2&$$!*.E-0LPL&T6Q&?.E0SA*3ZC3-=BR,9WT5=4XS:NX3HP]CL
MPFOI5@R)Q'JW#&TII912.M@,5FC;XFC#SK(#^//A=S%DXT]QY?H?*5Z]X2=X
M_?AH5+15JUL20@@A)-QH:C,@,?<1Q!JOT0PBJ3[C4X<A+O5&%%7/AMMM4WN7
M$-_84>/$$RD6?"62ZMTRM*644DKI8#,8H6U&8QXFF!9@Q-:',63C?1B^Y4'<
MM.4AQ:&;?XX;A1-2%\#&<@F$$$)(6.+V.)%1\B9+)/13&7JG%KX,J[U$[5E"
M^H;%[<'"4CM^?$+6NVWREDP(YWJW#&TII912.M@,9&A;;:G#MI(8/!;[.H9L
M^*D2T+:'M>W* /?&30_@1[N?AMG>I#Z2$$(((>%&2<UBEDCHLR.4P/98UD_0
MT'),[5%"^H^L=SL^SX8[CG2H=QN.X2U#6THII90.-@,5VB;7I^.MA(E**'O=
MQOM/"6L[>L.F!W#G]M^BP=ZH/IH00@@AX4:3Q8C$W$<1:QRB$4K2GHPWW2A^
MCD!IW7+1DQYOAQ+B1TS-+OPUW8KKXL*TWJT,;;?4(6IN-D-;2BFEE X._1W:
MEK55877!9_CYWC_CVHWW8=CF7V@&M1V5H>W=G_V.H2TAA! 2QL@2">DE_T2,
MX5NGA)*T)X<CUG@ULDK_!X>S3NU-0@+#KAHGGC)8\-5PJW>[2[:W 5$+\Q U
M+DG[C0VEE%)*:23IK]#6Y7'A>$T*WC@^&L.V/(CK-SV@&=!JR="6$$((B0P*
MJV<JY1'D@EK: 27M:IQQ"!)R?H4FBTGM14("B]7MP>)2.^X[T8KSPZ7>+4-;
M2BFEE XV_1':RMFU"W/6X >[GO+.KMW2^^S:CC*T)8000B*#AI9#.)G]"\29
MKM4,*&EGXTS7XTCZG:@T;U)[D)#@41Y.]6X9VE)**:5TL-F?T-;JLN% =0)>
M.S92"6M]F5W;48:VA!!"2&3@<#4@M>A5Q!BNT PI:4>'(\XT!+D5X^!T\340
M&3A26USX6X85UX=RO5N&MI122BD=;/8UM"UH+L6T]&6XX[-',63#?<J"8UJ!
MK!X9VI)PP>5TPVYSJO\BA!"B15'U;)9(T*&L8YN<_P>TVG+4GB-D8-E=Z\33
MLM[M?AF0-H96>,O0EE)**:6#35]#VV9'*W:5'\1SA]_&M1M_J@2N6D&L+S*T
M):%.37D3CNS(POK9Q[!FQA$<W)J!Y/@"9":6H:*H ?55+;!9'.K6A! RN/&6
M2'B0)1)Z4/;-T<Q[4=NT3^TU0D(#6>]V2:D=]Y]HQ06A5.]6AK:[Q,]E10QM
M*:644CHX]"6T36W(QCCC/-RQ_5%<M^G^?LVN[2A#6Q+*-)NMF/ON'OS^QBEX
M=,AD_.[ZCY2?S]PV$V_<OP037MZ,F6_MPJHIAQ"SWH2$_;G(.%F*TMPZU%4V
MPV;AS%Q"R.!"*9%0^!)B#/^G&5@.=N4,Y#C3=<J,9+>''_B1T*3"YL;$?!ON
M#*5ZMWM%6SXI051THO8;&THII9322%)/:%MG,V-S\3[\)N85#-GP4]RXZ>>:
MX6M?96A+0IF=*U+P_)US\/CP:4I0V^[3M\S DS=/Q^/#IN(/0Z?B=S=,P6-#
M)HO_/06O_6011OUI':;_:P<^G7((.S].QJ'/,I%VO 2%&=6H+#+#VFI7CT (
M(9%'?N5DQ)J&0-9MU0HN![.QQFM@*GP1%ENAVEN$A"[I+2[\,\.*&^)#H-XM
M0UM**:64#B9["VT3ZU+Q;M(495;M=1OOUPQ=^RM#6Q+*C'EV/1X?/A7/W/I%
M8-N33XOME#!W^#1OF'O]1WCLVLEXY)I)>.5'"_'NXZLP\94M^&3R0>Q<\468
MFVNL1$5A UH:K7"[W>K1"2$D/*EMW(/C6?=#SBC5"BX'IR.4P%;V2V/K";6G
M" D/]M8Y\9<T*ZX[V(JHW<W><@5:P6H@96A+*:64TL%D=Z%MI:46G^9OP_U[
MG\.0C3_%L,V_T Q<_2%#6Q+*O/_46OQ^Z%3-@-97G[IY.IZX:1K^,$R=F=LA
MS'WS-Y]@PLN;L'1L+#;./XZ#VS)A.%2$'$.%$N8VUK6QU (A)&RP.ZI@+'@>
M^PU7:(27@]-XTXV(3QV.TKKEHH<\WHXB)(RHMKKPZ]@:1*VN\"X*%NSPEJ$M
MI9122@>374-;A]N)A#H3_G5R H9M?@C7;_J99M#J3QG:DE!FT_SC>.[..7CB
MINF:0:P_](:YWE(+,LS][74?X9%K)N//=\_%OW[UL5(W=_[_]F+5E,.(WY*!
MQ+A\I)\L17D!PUQ"2.B25_DA8I7%R%@B01IKO!89)?^&S5&E]A AX4.>V8Z_
M[RO#)5.,B)IH0-3B D1MJ$;4#C.B]C1KAZS^5@EM2[D0&:644DH'AQU#6[O;
M@:5Y&W'?GF<Q9.-] 9U=VU&&MB24J2YIQ-N_^Q1/=*EI&PR?DG5S1WC#7+D0
MFBRU(,-<68+AM?L68_R+FS#_/6^8>V!+.D[LS47:B5*4Y-2AMJ(9UC8N<$,(
M&3AJF_:S1(+B",08KL+)G%^AJ<V@]@XAX4-<<0L>6IN'J+%)XLW#%V\BHJ:F
M(FIY$:*VU"%J5R.B=@=XUJT,AU>5>T/CKF]J**644DHCS8ZA[8K\+;AMVV]P
MW:; U*[M3H:V)-39MC01S]\E9]L&/[C5LN,B:.UA[J/73%;^]ZL_7H11?UR'
M:?_\3*F;NW>U$<=VY2 CL0Q.ATL](T(("3RR1(*AX#G$&*[4"#('CW&F&\3/
M$:BH7ZOV#"'A@=GJPMR46EPS-QU1HS1*$LC@=H+X.3,342M+$;4MP"439&B[
MI@)1DTWBN.+87=M#*:644AI)=@QMO[?S<25$E8N.=0U6 RE#6Q+JF&M:\<[O
M5WD7)-,(44-%K470'ATR&;^_80K>^-D2;)Q['-8VNWI6A! 2>+++WD>LX6H,
MWA()PQ%GNA8YY:/@<-:KO4)(Z)-KMN'UO64X>[+!.\-6ZXU$N^/%W^7LU_FY
MB%I;&;AZMPQM*:644CJ8[!C:WKCYYYJA:J!E:$O" 3EC]?F[Y^+Q$)EMZXLR
MS)7E'?XP= KB-J7!8>>,6T)(<*AL6(\C&=^#=[9IUT S\HTU7H.4_"?19LM3
M>X20T">FN 4/KNE2#D&/<N:M#%07YR-J?0#JW3*TI9122NE@LF-H.S1(-6R[
MRM"6A ,NAPMC_[Q163#LZ5MG:(:CH6S[+-RQ+VQ 766S>E:$$!)8K/92I.3_
M4:GIJA5J1K*REN_AC#M1T[A3[0U"0IL&JPMSDFMQ]=PT[7((>I1AJ@QO/Z]W
M6^N_>K?MH>U'#&TII912.@CL&-H^$OL:;MST (9M9GD$0K0XMBL;?[EG/OXP
M++3+)'2G7-CLW3^L0E4)[S5"2/ 8C"42XE.'0<XNSJ^<!*>K2>T)0D*7G 8;
M7MU3BK,GZ2B'H$<9W':J=UO?_Y()>UL0M;I<[%^TD:$MI9122B/=CJ%M7,5Q
M_";F57QK_0]QU?H?X_I-/PM*?5N&MB1<<-J=&/_R9CPQ(OQFV\J9MH\/FX9%
MH_:CM<FJGA$AA 2>RH8-.))Q#P93B808XY4P%OX%%GNQV@N$A"[[BUKP\]5]
M*(>@QX[U;N4LV;[6NY6S=>5CEA4B*KJ/LX II9122L/)CJ&M?-%VN"H1_TF<
MA"</_ L_V/4DKMGX4URYX4>X;N/]&!:@\@DRM/W.]L<8VI*PP'"X$*_]9)&R
MV)=6.!JJRI#Y3W?,1LJA0O5,""$D.%CL14C.?WJ0E$@8@3CC$!S-O!<-+8?4
M'B D-)'E$&8GU>*J_I1#T*N<>3O9B*A%LMYME>_U;N6V&ZH1-3V=LVPII912
M.CCL&MJV4]12CBW%^S#:. ?/'WX;]^UY%C=N^CFN7/\C#-GX4PSUXZ)E<K_W
M[?X3S'9^?9"$!S/?VJF$H$_?$B:S;6^=B=\/G8KY[^]%:Y--/0M"" D.;H\3
MF:7_'12A;;QI* ZFC4!)S1)QW@ZU!P@)/4PU%KR\JP1G^:L<@AYEN00Y\W9*
MAWJW,I#MK=ZM#&QER+LPGX$MI9122@>/W86V':FQUF-O^6%,3EN,EX^^CU_'
MO(*;M_X25ZS_(:[>\!-EIJQ6&*M'67YA^.8'\=SA_Z+%T:8>D9#0)B.A%*_]
M=%'8U+9]ZN;I>/7'"U&<5:.> 2&$!)?2VJ4XE'8;XE-OU P[(\58PU7(*/D7
M[$X^WY+0Q.7Q8%MN(^Y9GNV=7>OO<@AZE+-NV^O=?B+KW:HE$V1X*TL@M"O_
M+0-;65)A28&WS )#6THII90.%O6$MAV1P6IB71KF9:_"WT]$XP_Q?\=W=_Q>
M"7#[4@=7"6V%+QY]#ZU.AK8D?%CPP3XU$ WMV;9*+=OA4[%YX0G8K9SU10@9
M&)HM:4C,_2UBC=><$G1&AB,08[P*"=D/H:DM63UK0D*+FC8G/CQ6C:_/2D74
MZ!"H"]M>[W9>#J)6E2-J4ZTWP/W,[/VYJ<9;!W=>MC>LE4&OUGXHI9122B-1
M7T/;CK@\+F0V%F!-P0ZE#N[3!_^-'^YZREL'=[V^.KCMH>VS<J:MLU7=,R&A
M3T5! _[U\/*0GVW[Q$W3\-8CGZ"JA#6C"2$#AP?B-4/IVQ%;(B'>= ,.IMV"
MRH:-ZAD3$EH8:BQX[K-B;_ 9':1R"'H=IX:WL[(0M3 /48L+O#]G97A_+_^N
M]3A**:64TDBV/Z%M5XI;RK&U9#_&&N?BST?>P?U[GL.-F[UU<&60JU4'=]B6
M7XAM'L#;21_!ZF*M31)>?#P^3@E&GQPQ_92P-!24=7>?^?9,Q&].A\OA5EM-
M""$#0UGML@@MD3 <L<:KD5,^"@YG@WJVA(0&3K<'6W(:\=WV<@BA/%M5EDV0
MLV]E2"M_MI=1T-J64DHII332]6=HVY%:6P/VE1_!E/0E>/782/PF]E7<TJ$.
M[K4;[U,6-)/__NGN/R&AU@2/^#]"PHGR_ :\_=M/\?A-TS1#TX%6S@+^Z*_;
MT,+%QP@A(4!3FP&)N8\BUCA$(_@,7V7)A\2\1]%BR53/E)#0H+K-B0G'JO&U
MF2%2#H%22BFEE.HW4*%M1UJ=%B379V!!]FK\X\0X/'[@'WAX_XMX:-]?\)<C
M_\/6DAAU2T+"C\^6)^'YN^<J90BT@M.!\NE;9N"%[\Y#ZK$2M:6$$#*PN-P6
MI!?_ S&&*S3#SW TSG0=CF1\%]6-GZEG24AHD%)MP9^V%WEGJK*\ *644DII
M^!F,T+8C+H\;V4V%.%*=A*/5R:BVUJM_(20\::QKPWM/KL;CPT,HM+UU)GYW
MPQ0L'Q<'2ZM=;2DAA P\Q=5S<2!U&.)3AYX2@(:?PQ%KNA9YE1/A=#>K9TC(
MP"++(6S*;L3=R[-"OQP"I9122BGMWF"'MH1$(CL^3L9S=\T)F3()LL;N7Q]8
M@I+L6K6%A! 2&IA;CN)D]D-*V*D=A(:/L<:K8"AX%FVV O7L"!E8JMJ<&'^T
M"I?/8#D$2BFEE-*PEZ$M(?U'SK8=^_P&)2Q5%O_2"%*#Y=.WSL13MTS'KD^2
MX;"[U!820DAHX'0U(JWXC; OD1!GNA;',G^ AI8CZID1,K#(<@A_9#D$2BFE
ME-+(D:$M(?[AQ-Y<O/C]^<KB7UIA:K"491I&/K,6M>5-:LL(\0^N%CO:\NK1
MFET+:TFC^EM"?"?<2R3$B[;'F:X7YS$?'H]#/2M"!@:60Z"44DHIC5 9VA+B
M'YP.%\;]99,2F@[4;%MYW.?NG(/CNW/@=KG5EA'2=QQU;6@X4(CRCU.0^<^=
M2'YT%9)^^0F,3ZU#_OAXU(N_$>(KYI9C2,AY&'*VJE8H&NK&&J]!:M&KL-BY
MT",96"I;'8@^PG((E%)**:41*4-;0OQ'<GP!7OWQ(CP^;&!JV_YAZ%3,_,\N
MM+78U!81XCOM06WI@I-(?V4K#@^?B=VGO8?=4?_#GC,_P-ZS/L">,S[ SJAW
M<&CH=!3/.:[,PB5$+[)$@JGH)>PW?$LS% U=1R#&>#5.9O\<36U)ZMD0,C D
M55GP]-8B\6)>O*!G.83!JU(.(QE1T6(,^*)\S 2AUCY#1?%&5;/M/2GO!?DX
MK?U1ZJN^C$$]XT[OO1H.]R>E-#@RM"7$O\QY>Y=25_;IFX,[V_8I<;R7OK\
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MMJM[Z9W$*@N^.CMMX(.S4 QMQ7[/$/Y6Y\Q728'H>WGOZAY;'97G(61H2^D
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MGN3NK21)"S^C+0  P/RVL74X+M_8$9^XNR:6+"^\D4M^<)G3"9(D+=R,M@
M *6AMG<T;J_JB:^L:HBW7+BE^.3M4N.M)$D++J,M  ! :>D9R<:JZOXX[=F6
M>/]UVXHW;Y.<3I D:6%DM 4  "A-^4+KFH?B^^O:X_=NW1G'G%,6J=.=3I D
MJ>0SV@(  )2^RHYTW%;9'5]XJ#[>]/W-D3IM7:3.,MY*DE22&6T!   6CL[A
M3#Q<W1???JHY?O[*RN*3MTXG2))46AEM 0  %IYL/F+M[L$X[^6V^.V;=D9J
MV4:G$R1)*I6,M@    M;14<ZKM_<%7]U?UV\^<(MD3IMO=,)DB3-YXRV
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MI):Z>RM)FN.,M@   "QVF7P^-K4-Q_6;N^(/;MM5?.HV&7"=3I DS45&6P
M -AK1_=(W%[5$U]\N"'>?.$6=V\E2;.?T18    .UC&4B2?K!^*T9YKC%ZZN
MC-293B=(DF8IHRT   "\NM%L/M:U#,5EFSKCY!].G$Y(!MQEGKZ5),U01EL
M  "8FET](_'#RI[XS/VU<>+YY4XG2))F)J,M    ')JF@;%XO&X@_NWIYOC9
MR[8ZG2!)FMZ,M@   '!XTIE<O-@T%!>L:X\/W+"]^-2MTPF2I"/-: L   !'
M;DM[.F[9VAU_>G=-_/@*IQ,D24>0T18   "F3WW?:#Q2TQ__]$1C_*?+*B+U
MW?7%'UXVV9MR29(FRV@+    TV]@+!?/-0[&LN=;X]>2TPGNWDJ2IIK1%@
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MXM/WUL51RS<YG2!I\66T!0   .:CIH&Q6%/7']]ZLBE^]O*M3B=(6CP9;0$
M (#Y;& T%V5MPW')^H[XC1_L* ZWR?D$XZVDA9K1%@   "@%N7S$]JZ1N*VR
M)SYQ=TT<L[QLXNZMTPF2%EA&6P   *#4[.X?B\=J!^*KJW?'6R_>XNZMI(65
MT18    H55WI;&QH'8X+U[7'+UY3Y>ZMI(61T18    H==E\Q-;.=-Q<T14G
MW[XKCCW7Z01))9S1%@   %A(ZGI'8W5-?WS^H8;XC\GIA*5.)T@JL8RV
MP$+4/I2)YYL&XSO/-,=_O38YG3 QWCJ=(&F^9[0%    %K*AL5Q4=*3CJDV=
M\;';=A:'V_'3"9,,)9(T'S+: @   (M%;>]HK*KIB\_=7Q?'GC-Q]S89<2<;
M321IKC+: @   (M-VV FUC8,Q+^O;8EW75$9J3.=3I TCS+: @   (O5X%@N
MMG2DXXJ-'?&;-^V(U/<V1>HLXZVD.<YH"P   "QV^4*[>D;BSFT]\<F5M7'<
MN1.G$Y89<"7-049;    @+V:!L;BR8:!^/O'&N.G+ZF(U%*G$R3-<D9;
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MSOC(+3N+0XS3"9*FDM$6    8&;5]H[& [OZXO,/-8P/,<7QUH KZ54RV@(
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MOOC< _5QXOE.)T@ED]$6    8&%K'\K$\XV#\7>/-<8[]YQ.,-Y*\S>C+0
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M'V\-N%K(&6T!    F,^&,[FH[1V-.ZIZXG=NV5D<;_>]?3O9Z"65<D9;
M $I%X\!8/%K;'Y][H"[>_,KIA(DF&[^D4LQH"P   $"IZ1K.1GG[</S+4TWQ
MWE=.)^S39$.85"H9;0$    H58-CN=C9/1*7;NB(W[UUS^F$0DXGJ)0SV@(
M  !0ZC*Y?#0-C,5].WKC?]Y?%R><5V:\5>EFM 4   !@(>D<SL:FMN'XQR>:
MXBT7[KE[.S'>&G!5"AEM 0   %B(^D=S4=F9CDO6=\0'?K!][VCKZ5O-]XRV
M     "QDR>F$QOZQN'=';_S)RIHXX;QRIQ,TOS/: @   +!8M ]EXIG=@_'5
MU;OW.9TPT63CF307&6T!    6&QZ1[*QM6,DEKW0&N^[IFKO<.OI6\V'C+8
M    +%;I3"[J^T;CGNV]\;';=A4'6Z<3--<9;0$    @HG4P$T\U#,2I#S7$
M3R:G$UYY^G:?,4V:C8RV     +!7=SH;%1WI^/>U+?&^:[;M,]YZ^E:SE-$6
M      XV-):+NKZQN&5K=_%TPOB85LAXJYG.: L     KRY?J&4P$P]5]\7_
M>K ^7G=^N2=O-;,9;0$   !@:I+3"5LZAN/;:YOCG5=43HRW209<36-&6P
M   X-,GIA.J>T;AB4V=\^*8=Q<'6Z01-5T9;     #@\F5P^F@?&XL%=??&I
M>VKC]4XG:#HRV@(   # D>L<SL9+S4/QKT\UQ]LNWC(QWB89<'6(&6T!
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M,X[:<SK!W=O%D]$6     .:?;#X_?CKAD9K^^,Q]=?N<3DC&6Z<3%G1&6P
M  "8W[K3V5C?.ARG/=,2/W-I11R5#'M.)RS<C+8     4!K2R>F$WM&XIKPK
M?NV&[7'T\C+C[4+,: L     I24YG= Z6#R=\(F[JN,-%Y07QSYW;Q=&1EL
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MC&/.661/WQIM 0   (#Y:#B3B\;^L5CQ<GO\\O7;BZ<3)D;-!3W>&FT!
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MN:HJCCMW'IY.,-H"     (O-R,3IA$LW=,1';]E9/)TP,9C.^>D$HRT
ML%AE<OGH3F?BWAU]XZ<3?GS%YCAZ^3ZG$R8;56<ZHRT     0,3@6"[6-0_%
M/S_9%"==6A''G3-'=V^-M@      >Z4SR>F$L;AH?7N\]^JJ."&Y>SLQIL[*
M>&NT!0     X6'(ZH6,X&_=L[XT_65D;)ZXHCZ,G1M7Q#AQ;IRNC+0    #
M:QL8S<6ZEJ'XV\=VS_SI!*,M     ,#4#&=R4=TS&A=OZ(C_<LVVXNF$9+2=
MSO'6: L     <&B2TPF=PYFX:6M7?.R'N^+$\\MCR<3@FEIVA*<3C+8
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MR>:CKF\T+MG0$1^\<7N<MK;9: L     ,!\D3]_NZ$[G_S^R+%=+X!:N;
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139971454773632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Evolent Health, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0454912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">800 N. Glebe Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Arlington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">389-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">22203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EVH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001628908<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>evh-20230119_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="evh-20230119.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001628908</identifier>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-22">2023-01-19</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001628908</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-01-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Evolent Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37415</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">32-0454912</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">800 N. Glebe Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Arlington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">22203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">571</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">389-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">EVH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !YC$U7JL0B%C,!   B @
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( 'F,35=ED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !YC$U7)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " !YC$U799!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="evh-20230119.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.evolenthealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" isOnlyDei="true" original="evh-20230119.htm">evh-20230119.htm</File>
    <File>evh-20230119.xsd</File>
    <File>evh-20230119_lab.xml</File>
    <File>evh-20230119_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "evh-20230119.htm": {
   "nsprefix": "evh",
   "nsuri": "http://www.evolenthealth.com/20230119",
   "dts": {
    "inline": {
     "local": [
      "evh-20230119.htm"
     ]
    },
    "schema": {
     "local": [
      "evh-20230119.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "evh-20230119_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "evh-20230119_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.evolenthealth.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "evh-20230119.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "evh-20230119.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001628908-23-000149-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628908-23-000149-xbrl.zip
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M,UC$\,  L0LIG 3&(@E6"B&#V">.)'%MZHC=O/.!1V-?JF,[K6:-G"TNYTN
MW^%J#SUGJ#BF0L56R+YG;O+44D^M=%]:31X 4*)>G0%.51$U1U$*0HT"K 4;
M^=1ER3YGBJS"'M&)$DY3# 4&O,LE*9<-&T?BB!6>9A3PU/4"2^)U< XT#Z9O
M39S/CV)Z=R4CY49FF80GF#$^1!+S!/(X%1;-\<;9R!N#X!("$*<3PE_6#\%
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M8G5@PDFH32%WTNB6L\'DV13&IC(;;=Q%>97Q8B?W\G$N4CNE1(2H[T> 8\(
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M.O38&7RGDX[-2'L=<)2.!C_7V(1?=YQ1^;QK67MF'65\]LGVLP__UH]3!,,
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M.@BZ/O0>6G[A<& 9UX>SK> &NR;Q;C)NY?[GZ:OU._'R;^B?OOH_4$L#!!0
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M!C#<&FO9N';V7\U@&"@3[EKN5>+7WE @7..F>,^XORS:$G(A8[ *.'$6$'7
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MW<-Z\)79811,O@\Y1LR]T?!V\43$<SQP_.;Q@^ZA^\?$\9O_ %!+ P04
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M@7E\AK5I_D8]JUOYU>YUWJ.-IGWH?3LV>^QEJ#:IWM)8K=%@0;^)#^LUKCG
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M *K$*D.OA$,)QXK\6U_O#K=%[VF <!SK&K-I+=QC3C_BPQSH(G/U[-:O2EV
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MP@\X-RJ34J0K,.!7%J$#L@G772:!E(0J"6V>A%[84=1'R[<FX&+85LCH%"I
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M5ARV'6*CQ3PP5:Z+U'HVYOAW>9:00U%''+DC2.1Q<8^P]P?"ETITJ!30EL.
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M'T3@C 6D<E1+861YI3824EN1[X!N6F#;">@(Y GJK>(+-L2F)6CI(/YZQ%8
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M33\9G9Q_9%4X8/2S*G0V45<!<_:H\&.AN6QVJ)D["%H#X29ZQNJ5#6QS^<C
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M>B4B:2ICL@ !2J4N&:=X0>N94PE()9167#K99!KX\YQ'FH/^C3K(X3K%F^L
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MCQ-E1R[]+M'RU,O#2F-\TP^XS/ 30R:+N#]%+Y+8I +="3Y%>)(+EX(LK*2
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M_-;QKJJT2ZT[,-<2+^6/^;1CK??=TH[O?.PT4Z$<1 KU?L?8:N$0N[94IH_
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M6\E45.ZW9N(!T50?(]+H&4JO3,I4-C[8)J#]W-R >@7+IY7!\CM>Q@.D(K,
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M^BF/K3W'?GDTU<C^[W6-LDKMRG/LXRW9^F7BVTOXOUDT=W_[7U!+ 0(4 Q0
M   ( 'F,35=:!7P^3Q   &1[   0              "  0    !E=F@M,C R
M,S Q,3DN:'1M4$L! A0#%     @ >8Q-5]YIOF!M @  ? <  !
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>=#DY,BYH=&U02P4&      8 !@!X 0  BZ@

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
